Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,194,910
-
Total 13F shares
-
1,627,492
-
Share change
-
+1,627,492
-
Total reported value
-
$8,756,000
-
Price per share
-
$5.38
-
Number of holders
-
14
-
Value change
-
+$8,756,000
-
Number of buys
-
14
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2021
As of 31 Dec 2021,
Journey Medical Corp - Common Stock (DERM) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,627,492 shares.
The largest 10 holders included
B. Riley Financial, Inc., Neuberger Berman Group LLC, AMERICAN FINANCIAL GROUP INC, PERKINS CAPITAL MANAGEMENT INC, Millrace Asset Group, Inc., CANNELL CAPITAL LLC, GOLDMAN SACHS GROUP INC, B. Riley Wealth Management, Inc., CITADEL ADVISORS LLC, and Tudor Investment Corp Et Al.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.